BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder Cancer in the 21st Century. J Oncol. 2015;2015:967472. [PMID: 26421012 DOI: 10.1155/2015/967472] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 15.1] [Reference Citation Analysis]
Number Citing Articles
1 Yang D, Zhan M, Chen T, Chen W, Zhang Y, Xu S, Yan J, Huang Q, Wang J. miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer. Sci Rep 2017;7:43109. [PMID: 28256505 DOI: 10.1038/srep43109] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
2 Deng Y, Pang Q, Bi J, Zhang X, Zhang L, Zhou Y, Miao R, Chen W, Qu K, Liu C. A promising prediction model for survival in gallbladder carcinoma patients: pretreatment prognostic nutrient index. Tumor Biol 2016;37:15773-81. [DOI: 10.1007/s13277-016-5396-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
3 Singh L, M. K, Rija M, Manoharan R. Management of a Suspected Case of Gallbladder Cancer with Individualised Homoeopathy: A Case Report. Homœopathic Links 2021;34:300-6. [DOI: 10.1055/s-0041-1740239] [Reference Citation Analysis]
4 Chen H, Wu X, Duan Y, Zhi D, Zou M, Zhao Z, Zhang X, Yang X, Zhang J. Ursolic acid isolated from Isodon excisoides induces apoptosis and inhibits invasion of GBC-SD gallbladder carcinoma cells. Oncol Lett 2019;18:1467-74. [PMID: 31423212 DOI: 10.3892/ol.2019.10397] [Reference Citation Analysis]
5 Sun L, Cai J, Gonzalez FJ. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Nat Rev Gastroenterol Hepatol 2021;18:335-47. [PMID: 33568795 DOI: 10.1038/s41575-020-00404-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 43.0] [Reference Citation Analysis]
6 Adachi T, Haraguchi M, Irie J, Yoshimoto T, Uehara R, Ito S, Tokai H, Noda K, Tada N, Hirabaru M, Inoue K, Minami S, Eguchi S. Gallbladder small cell carcinoma: a case report and literature review. Surg Case Rep 2016;2:71. [PMID: 27457076 DOI: 10.1186/s40792-016-0200-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
7 Liu Z, Yan C, Xiao Y, Zhang W, Wang L, Li Q, Cai W. Expression and inhibitory effects of p53-upregulated modulator of apoptosis in gallbladder carcinoma. Oncol Lett 2021;21:234. [PMID: 33613723 DOI: 10.3892/ol.2021.12495] [Reference Citation Analysis]
8 Campbell PT, Newton CC, Kitahara CM, Patel AV, Hartge P, Koshiol J, McGlynn KA, Adami HO, Berrington de González A, Beane Freeman LE, Bernstein L, Buring JE, Freedman ND, Gao YT, Giles GG, Gunter MJ, Jenab M, Liao LM, Milne RL, Robien K, Sandler DP, Schairer C, Sesso HD, Shu XO, Weiderpass E, Wolk A, Xiang YB, Zeleniuch-Jacquotte A, Zheng W, Gapstur SM. Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev 2017;26:597-606. [PMID: 28314823 DOI: 10.1158/1055-9965.EPI-16-0796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 4.2] [Reference Citation Analysis]
9 Kumar S, Masood S, Srivastava U, Madhavan SM, Chauhan S, Pandey A. Factors predicting recovery of liver function after percutaneous drainage in malignant biliary obstruction: the role of hospital-acquired biliary sepsis. Clin Exp Hepatol 2020;6:295-303. [PMID: 33511276 DOI: 10.5114/ceh.2020.102154] [Reference Citation Analysis]
10 Xue C, He Y, Hu Q, Yu Y, Chen X, Chen J, Ren F, Li J, Ren Z, Cui G, Sun R. Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer. Cancer Manag Res 2018;10:5101-12. [PMID: 30464610 DOI: 10.2147/CMAR.S184381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
11 Berger Y, Sullivan BJ, Leigh NL, Bekhor EY, Dhorajiya P, Mani M, Magge DR, Cha DE, Sarpel U, Hiotis SP, Labow DM, Ward SC, Golas BJ, Cohen NA. Gallbladder Cancer: A Single-Institution 10-Year Experience-Analysis of Adenocarcinoma Subtypes and Tumors Arising from Intracholecystic Papillary Neoplasms. Ann Surg Oncol 2022. [PMID: 35437668 DOI: 10.1245/s10434-022-11719-6] [Reference Citation Analysis]
12 He Y, Xue C, Yu Y, Chen J, Chen X, Ren F, Ren Z, Cui G, Sun R. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Manag Res 2018;10:3857-65. [PMID: 30288117 DOI: 10.2147/CMAR.S175681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
13 Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surg Oncol. 2019;31:83-89. [PMID: 31541911 DOI: 10.1016/j.suronc.2019.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Yang D, Chen T, Zhan M, Xu S, Yin X, Liu Q, Chen W, Zhang Y, Liu D, Yan J, Huang Q, Wang J. Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer. Mol Ther Oncolytics 2021;20:59-70. [PMID: 33575471 DOI: 10.1016/j.omto.2020.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhou F, Zhang Y, Sun J, Yang X. Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma. Cancer Cell Int 2019;19:190. [PMID: 31367188 DOI: 10.1186/s12935-019-0911-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Ying H, Fengying S, Feng H, Yanhong W, Xianru X, Xiaolei T. Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme. Transl Oncol 2021;14:100928. [PMID: 33212417 DOI: 10.1016/j.tranon.2020.100928] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol 2019;13:157-71. [PMID: 30791781 DOI: 10.1080/17474124.2019.1549988] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kumar R, Kumar R, Tanwar P. Structural based screening of potential inhibitors of SMAD4: a step towards personalized medicine for gall bladder and other associated cancers. Mol Divers 2021;25:1945-61. [PMID: 33751339 DOI: 10.1007/s11030-021-10210-w] [Reference Citation Analysis]
19 Yadav S, Chandra A, Kumar A, Mittal B. Association of TERT-CLPTM1L and 8q24 Common Genetic Variants with Gallbladder Cancer Susceptibility and Prognosis in North Indian Population. Biochem Genet. 2018;56:267-282. [PMID: 29450669 DOI: 10.1007/s10528-018-9843-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Xu L, Tan H, Liu X, Huang J, Liu L, Si S, Sun Y, Zhou W, Yang Z. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013). Cancer Med 2020;9:3668-79. [PMID: 32233076 DOI: 10.1002/cam4.2989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ma F, Yang Y, Wang J, Quan Z, Zhou D. Helicobacter pylori and 17β-estradiol induce human intrahepatic biliary epithelial cell abnormal proliferation and oxidative DNA damage. Hepatobiliary & Pancreatic Diseases International 2017;16:519-27. [DOI: 10.1016/s1499-3872(17)60038-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
22 Spolverato G, Bagante F, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Winslow E, Cho C, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer. World J Surg 2017;41:224-31. [PMID: 27549595 DOI: 10.1007/s00268-016-3691-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
23 Shen H, Zhan M, Zhang Y, Huang S, Xu S, Huang X, He M, Yao Y, Man M, Wang J. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Cell Death Dis 2018;9:71. [PMID: 29358655 DOI: 10.1038/s41419-017-0107-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
24 Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget 2017;8:3104-10. [PMID: 27902971 DOI: 10.18632/oncotarget.13621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Jung J, Chae Y, Kim CH, Lee Y, Lee JH, Kim D, Yu Y, Kim JY. Combined Adenosquamous and Large Cell Neuroendocrine Carcinoma of the Gallbladder. J Pathol Transl Med 2018;52:121-5. [DOI: 10.4132/jptm.2017.08.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 Dong Y, Xu B, Cao Q, Zhang Q, Qiu Y, Yang D, Yu L, Wang WP. Incidentally detected focal fundal gallbladder wall thickening: Differentiation contrast enhanced ultrasound features with high-resolution linear transducers. Clin Hemorheol Microcirc. 2020;74:315-325. [PMID: 31524151 DOI: 10.3233/ch-190697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Gupta A, Gupta S, Rajput D, Durgapal P, Chennatt JJ, Kishore S, Rao S, Dhar P, Gupta M, Kant R. Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma. J Carcinog 2021;20:11. [PMID: 34729043 DOI: 10.4103/jcar.JCar_9_21] [Reference Citation Analysis]
28 Wang J, Yao Y, Ming Y, Shen S, Wu N, Liu J, Liu H, Suo T, Pan H, Zhang D, Ding K, Liu H. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. Sci Rep. 2016;6:28833. [PMID: 27349455 DOI: 10.1038/srep28833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lu W, Hu Y, Ma Q, Zhou L, Jiang L, Li Z, Zhao S, Xu Y, Shi W, Li S, Liu Y. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Oncotarget 2016;7:62364-76. [PMID: 27577078 DOI: 10.18632/oncotarget.11634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
30 Corwin MT, Khera SS, Loehfelm TW, Yang NT, Fananapazir G. Incidentally Detected Focal Fundal Gallbladder Wall Thickening at Contrast-Enhanced Computed Tomography: Prevalence and Computed Tomography Features of Malignancy. J Comput Assist Tomogr. 2019;43:149-154. [PMID: 30371615 DOI: 10.1097/rct.0000000000000802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
31 Malik MA, Malik SA, Haq MG, Bangri SA, Ahmad SZ, Shah OJ, Shah ZA. Role of Glutathione-S-Transferases in Gallbladder Cancer and Cholelithiasis Susceptibility and Meta-Analysis. Nutr Cancer 2020;72:984-91. [PMID: 31755784 DOI: 10.1080/01635581.2019.1661503] [Reference Citation Analysis]
32 Qin Q, Liu M, Wang X. Gallbladder sarcomatoid carcinoma: Seven case reports. World J Clin Cases 2020; 8(17): 3881-3889 [PMID: 32953868 DOI: 10.12998/wjcc.v8.i17.3881] [Reference Citation Analysis]
33 Jin L, Cai Q, Wang S, Wang S, Mondal T, Wang J, Quan Z. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer. Cell Death Dis 2018;9:1017. [PMID: 30282996 DOI: 10.1038/s41419-018-1064-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
34 Fatima N, Srivastava AN, Nigam J, Raza ST, Rizvi S, Siddiqui Z, Kumar V. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study. Asian Pac J Cancer Prev 2019;20:1895-900. [PMID: 31244315 DOI: 10.31557/APJCP.2019.20.6.1895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Tsuchiya Y, Mishra K, Kapoor VK, Vishwakarma R, Behari A, Ikoma T, Asai T, Endoh K, Nakamura K. Plasma Helicobacter pylori Antibody Titers and Helicobacter pylori Infection Positivity Rates in Patients with Gallbladder Cancer or Cholelithiasis: a Hospital-Based Case-Control Study. Asian Pac J Cancer Prev. 2018;19:1911-1915. [PMID: 30051672 DOI: 10.22034/apjcp.2018.19.7.1911] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
36 Pandey P, Siddiqui MH, Behari A, Kapoor VK, Mishra K, Sayyed U, Tiwari RK, Shekh R, Bajpai P. Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome. Anticancer Agents Med Chem 2019;19:2019-33. [PMID: 31345154 DOI: 10.2174/1871520619666190725122400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Wang S, Wang Y, Wang S, Tong H, Tang Z, Wang J, Zhang Y, Ou J, Quan Z. Long Non-coding RNA FIRRE Acts as a miR-520a-3p Sponge to Promote Gallbladder Cancer Progression via Mediating YOD1 Expression. Front Genet 2021;12:674653. [PMID: 34168678 DOI: 10.3389/fgene.2021.674653] [Reference Citation Analysis]
38 Arslan E, Aksoy T, Dursun N, Gürsu RU, Sevinç MM, Çermik TF. The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas. Turk J Gastroenterol 2020;31:105-12. [PMID: 32141818 DOI: 10.5152/tjg.2020.19410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Shukla R, Shukla P, Behari A, Khetan D, Chaudhary RK, Tsuchiya Y, Ikoma T, Asai T, Nakamura K, Kapoor VK. Roles of Salmonella typhi and Salmonella paratyphi in Gallbladder Cancer Development. Asian Pac J Cancer Prev 2021;22:509-16. [PMID: 33639667 DOI: 10.31557/APJCP.2021.22.2.509] [Reference Citation Analysis]
40 Jiang X, Li C, Lin B, Hong H, Jiang L, Zhu S, Wang X, Tang N, Li X, She F, Chen Y. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway. Cancer Sci 2017;108:1144-56. [PMID: 28295868 DOI: 10.1111/cas.13236] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
41 Chen P, Yang T, Shi P, Shen J, Feng Q, Su J. Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis. Photodiagnosis Photodyn Ther 2022;37:102712. [PMID: 34995788 DOI: 10.1016/j.pdpdt.2022.102712] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Imaoka Y, Kuranishi F, Miyazaki T, Yasuda H, Ohno T. Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reports. World J Surg Oncol 2017;15:170. [PMID: 28893260 DOI: 10.1186/s12957-017-1245-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
43 Deng Y, Xu MF, Zhang F, Yu X, Zhang XW, Sun ZG, Wang S. Prognostic value of preoperative lymphocyte-to-monocyte ratio in gallbladder carcinoma patients and the establishment of a prognostic nomogram. Medicine (Baltimore) 2020;99:e21021. [PMID: 32756087 DOI: 10.1097/MD.0000000000021021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Liu W, Xiong Y, Wan R, Shan R, Li J, Wen W. The Roles of circMTO1 in Cancer. Front Cell Dev Biol 2021;9:656258. [PMID: 34277605 DOI: 10.3389/fcell.2021.656258] [Reference Citation Analysis]
45 Wang J, Jin Y, Li S, Song Q, Tang P. Identification of microRNAs associated with the survival of patients with gallbladder carcinoma. J Int Med Res 2020;48:300060520918061. [PMID: 32406793 DOI: 10.1177/0300060520918061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Li M, Chen L, Qu Y, Sui F, Yang Q, Ji M, Shi B, Chen M, Hou P. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing. Oncotarget 2017;8:36319-30. [PMID: 28422736 DOI: 10.18632/oncotarget.16751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
47 Sun LJ, Guan A, Xu WY, Liu MX, Yin HH, Jin B, Xu G, Xie FH, Xu HF, Du SD, Xu YY, Zhao HT, Lu X, Sang XT, Yang HY, Mao YL. γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma. World J Gastrointest Oncol 2020; 12(9): 1014-1030 [PMID: 33005295 DOI: 10.4251/wjgo.v12.i9.1014] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhang W, Shi J, Li R, Han Z, Li L, Li G, Yang B, Yin Q, Wang Y, Ke Y, Li Q. Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating Mutation. Oncologist 2020;25:375-9. [PMID: 32045060 DOI: 10.1634/theoncologist.2019-0498] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
49 Yao WY, Wu XS, Liu SL, Wu ZY, Dong P, Gong W. Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00162-4. [PMID: 34507896 DOI: 10.1016/j.hbpd.2021.08.006] [Reference Citation Analysis]
50 Fujimoto T, Ohtsuka T, Nakashima Y, Gotoh Y, Date K, Mori Y, Sadakari Y, Takahata S, Oda Y, Nakamura M. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma. J Hepatobiliary Pancreat Sci 2017;24:103-8. [PMID: 28002646 DOI: 10.1002/jhbp.421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Hashimoto S, Nakaoka K, Kawabe N, Kuzuya T, Funasaka K, Nagasaka M, Nakagawa Y, Miyahara R, Shibata T, Hirooka Y. The Role of Endoscopic Ultrasound in the Diagnosis of Gallbladder Lesions. Diagnostics (Basel) 2021;11:1789. [PMID: 34679486 DOI: 10.3390/diagnostics11101789] [Reference Citation Analysis]
52 Dixit N, Trivedi S, Bansal VK. Clear-Cell Adenocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature. Gastrointest Tumors 2021;8:52-7. [PMID: 33981682 DOI: 10.1159/000512955] [Reference Citation Analysis]
53 Chantarojanasiri T, Hirooka Y, Kawashima H, Ohno E, Kongkam P, Goto H. The role of endoscopic ultrasound in the diagnosis of gallbladder diseases. J Med Ultrason (2001) 2017;44:63-70. [PMID: 27619811 DOI: 10.1007/s10396-016-0742-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
54 Shiihara M, Ishikawa T, Saiki Y, Omori Y, Hirose K, Fukushige S, Ikari N, Higuchi R, Yamamoto M, Morikawa T, Nakagawa K, Hayashi H, Mizuma M, Ohtsuka H, Motoi F, Unno M, Okamura Y, Kinoshita K, Furukawa T. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers. Eur J Cancer. 2021;148:239-250. [PMID: 33752134 DOI: 10.1016/j.ejca.2021.01.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
55 Fujimoto G, Yamada S, Kusanagi H, Uegami W. Rapidly growing neuroendocrine carcinoma of the gallbladder: A case report. Radiol Case Rep 2020;15:259-65. [PMID: 31956384 DOI: 10.1016/j.radcr.2019.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Lugo A, Peveri G, Gallus S. Should we consider gallbladder cancer a new smoking‐related cancer? A comprehensive meta‐analysis focused on dose–response relationships. Int J Cancer 2020;146:3304-11. [DOI: 10.1002/ijc.32681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Rai R, Kim JJ, Misra S, Kumar A, Mittal B. A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations. Int J Mol Sci. 2015;16:28038-28049. [PMID: 26602921 DOI: 10.3390/ijms161226077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
58 Wei D, Rui B, Qingquan F, Chen C, Ping HY, Xiaoling S, Hao W, Jun G. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer. Int J Biol Sci 2021;17:514-26. [PMID: 33613109 DOI: 10.7150/ijbs.54074] [Reference Citation Analysis]
59 Ayoub M, Jabi R, Achraf M, Benani A, Soumia EA, Imane K, Mohamed B. Surgical management of gallbladder carcinosarcoma: A case report and review of the Literature. Int J Surg Case Rep 2020;75:460-3. [PMID: 33076195 DOI: 10.1016/j.ijscr.2020.09.114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Parida GK, Panda RA, Agrawal K. Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis. Nucl Med Commun 2021;42:846-54. [PMID: 33741859 DOI: 10.1097/MNM.0000000000001405] [Reference Citation Analysis]
61 Khurram R, Khamar R, Lunat R, Novelli D, Ozretić L, Chaudhary K. Gallbladder carcinosarcoma masquerading as a hepatic abscess. Radiol Case Rep 2021;16:152-6. [PMID: 33240458 DOI: 10.1016/j.radcr.2020.10.058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Zhang Y, You WH, Li X, Wang P, Sha B, Liang Y, Qiu J, Zhou J, Hu H, Lu L. Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment. Ann Transl Med 2021;9:889. [PMID: 34164523 DOI: 10.21037/atm-21-2227] [Reference Citation Analysis]
63 Anjali K, Kumar T, Kumar P, Narayan G, Singh S. Association of nonsynonymous SNPs of nucleotide excision repair genes ERCC4 rs1800067 (G/A) and ERCC5 rs17655 (G/C) as predisposing risk factors for gallbladder cancer. Dig Liver Dis 2022:S1590-8658(22)00552-7. [PMID: 35780063 DOI: 10.1016/j.dld.2022.06.012] [Reference Citation Analysis]
64 Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 2020;11:871. [PMID: 33067424 DOI: 10.1038/s41419-020-03080-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
65 Zarog MA, Lyons EM, O'Leary DP, Byrnes GJ. Incidental small cell carcinoma of the gallbladder-an unexpected finding at elective cholecystectomy. J Surg Case Rep 2018;2018:rjy166. [PMID: 30057740 DOI: 10.1093/jscr/rjy166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Wang S, Zhang Y, Cai Q, Ma M, Jin LY, Weng M, Zhou D, Tang Z, Wang JD, Quan Z. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Mol Cancer 2019;18:145. [PMID: 31623628 DOI: 10.1186/s12943-019-1078-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 17.3] [Reference Citation Analysis]
67 Sepe LP, Hartl K, Iftekhar A, Berger H, Kumar N, Goosmann C, Chopra S, Schmidt SC, Gurumurthy RK, Meyer TF, Boccellato F. Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallbladder Cells. mBio 2020;11:e01911-20. [PMID: 32963006 DOI: 10.1128/mBio.01911-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Zhang X, Zhai T, Hei Z, Zhou D, Jin L, Han C, Wang J. Effects of Platycodin D on apoptosis, migration, invasion and cell cycle arrest of gallbladder cancer cells. Oncol Lett 2020;20:311. [PMID: 33093920 DOI: 10.3892/ol.2020.12174] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Tian L, Deng Z, Xu L, Yang T, Yao W, Ji L, Lu Y, Zhang J, Liu Y, Wang J. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway. Cell Death Dis 2018;9:1115. [PMID: 30389910 DOI: 10.1038/s41419-018-1145-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
70 Gomes AF, Fernandes S, Martins J, Coutinho J. Carcinoma of the gallbladder presenting as haemorrhagic cholecystitis. BMJ Case Rep 2020;13:e232953. [PMID: 32169978 DOI: 10.1136/bcr-2019-232953] [Reference Citation Analysis]
71 Cai Q, Wang X, Wang S, Jin L, Ding J, Zhou D, Ma F. Gallbladder Cancer Progression Is Reversed by Nanomaterial-Induced Photothermal Therapy in Combination with Chemotherapy and Autophagy Inhibition. Int J Nanomedicine 2020;15:253-62. [PMID: 32021178 DOI: 10.2147/IJN.S231289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Koimtzis GD, Chalklin CG, Carrington-Windo E, Ramsden M, Stefanopoulos L, Kosmidis CS. The Role of Fine Needle Aspiration Cytology in the Diagnosis of Gallbladder Cancer: A Systematic Review. Diagnostics (Basel) 2021;11:1427. [PMID: 34441361 DOI: 10.3390/diagnostics11081427] [Reference Citation Analysis]
73 Wang SH, Zhang MD, Wu XC, Weng MZ, Zhou D, Quan ZW. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion. Tumour Biol 2016;37:12867-75. [PMID: 27449039 DOI: 10.1007/s13277-016-5210-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
74 Liu L, Yan Y, Zhang G, Chen C, Shen W, Xing P. Knockdown of LINC01694 inhibits growth of gallbladder cancer cells via miR-340-5p/Sox4. Biosci Rep 2020;40:BSR20194444. [PMID: 32270853 DOI: 10.1042/BSR20194444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
75 Yadav S, DE Sarkar N, Kumari N, Krishnani N, Kumar A, Mittal B. Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations. Cancer Genomics Proteomics 2017;14:495-506. [PMID: 29109099 DOI: 10.21873/cgp.20059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
76 Xiang S, Wang Z, Ye Y, Zhang F, Li H, Yang Y, Miao H, Liang H, Zhang Y, Jiang L, Hu Y, Zheng L, Liu X, Liu Y. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene 2019;38:1269-81. [PMID: 30254209 DOI: 10.1038/s41388-018-0494-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
77 Lu L, Zhang S, Song Z, Lu W, Wang Z, Zhou Y. Long Non-Coding RNA LINC01410 Promoted Tumor Progression via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer. Front Oncol 2021;11:659123. [PMID: 34322379 DOI: 10.3389/fonc.2021.659123] [Reference Citation Analysis]
78 Tautenhahn HM, Brückner S, Rauchfuß F, Donndorf F, Ardelt M, Fahrner R, Tannapfel A, Settmacher U. [Precancerous and early stage cancer of the bile duct system]. Chirurg 2018;89:274-80. [PMID: 29177915 DOI: 10.1007/s00104-017-0553-6] [Reference Citation Analysis]
79 Flemming JA, Zhang-Salomons J, Nanji S, Booth CM. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study. Cancer 2016;122:2534-43. [PMID: 27183133 DOI: 10.1002/cncr.30074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
80 Zhu S, Yang J, Cui X, Zhao Y, Tao Z, Xia F, Chen L, Huang J, Ma X. Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer. Sci Rep 2019;9:1823. [PMID: 30755649 DOI: 10.1038/s41598-018-38396-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
81 Al Manasra AR, Bani Hani M, Qandeel H, Al Asmar S, Alqudah M, Al-Zoubi N, Nadig S, Hamouri S, Obeidat K, Al-Muqaimi N. Trends of Gallbladder Cancer in Jordan Over 2 Decades: Where Are We? Clin Med Insights Case Rep 2018;11:1179547618771699. [PMID: 29760576 DOI: 10.1177/1179547618771699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Liu B, Shen E, Liao M, Hu Y, Wu K, Yang P, Zhou L, Chen W. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer. Tumor Biol 2016;37:9875-86. [DOI: 10.1007/s13277-016-4863-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
83 Song X, Wang Z, Liang H, Zhang W, Ye Y, Li H, Hu Y, Zhang Y, Weng H, Lu J, Wang X, Li M, Liu Y, Gu J. Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling. Int J Biol Sci 2017;13:782-93. [PMID: 28656003 DOI: 10.7150/ijbs.18732] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
84 Ghartimagar D, Shrestha MK, Ruwanpathirana RE, Purbe D, Mishra S. Incidental finding of a large polypoidal gallbladder mass diagnosed as papillary adenocarcinoma – A case report. International Journal of Surgery Case Reports 2022;94:107046. [DOI: 10.1016/j.ijscr.2022.107046] [Reference Citation Analysis]
85 Xu A, Zhang Y, Hu H, Zhao G, Cai J, Huang A. Gallbladder Polypoid-Lesions: What Are They and How Should They be Treated? A Single-Center Experience Based on 1446 Cholecystectomy Patients. J Gastrointest Surg 2017;21:1804-12. [PMID: 28695432 DOI: 10.1007/s11605-017-3476-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
86 Aldossary MY, Alayed AA, Amr S, Alqahtani MS. Primary squamous cell carcinoma of the gallbladder: Report of a rare neoplasm from the Eastern Province of Saudi Arabia. Int J Surg Case Rep 2018;51:186-9. [PMID: 30176555 DOI: 10.1016/j.ijscr.2018.08.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
87 Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D, Quan ZW. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Tumour Biol. 2016;37:9721-9730. [PMID: 26803515 DOI: 10.1007/s13277-016-4852-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]
88 Lindnér P, Holmberg E, Hafström L. Gallbladder cancer - no improvement in survival over time in a Swedish population. Acta Oncol 2018;57:1482-9. [PMID: 29932778 DOI: 10.1080/0284186X.2018.1478124] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
89 Demirbaş F, Çaltepe G, Comba A, Bilgin MC, Eren E, Abbasguliyev H, Kalayci AG. Gallbladder Polyps: Rare Lesions in Childhood. J Pediatr Gastroenterol Nutr 2019;68:e89-93. [PMID: 30889123 DOI: 10.1097/MPG.0000000000002269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
90 Ting YY, John A, Maddern G, Kuan LL. Small cell neuroendocrine carcinoma of the gallbladder. ANZ J Surg 2021;91:E357-9. [PMID: 33012064 DOI: 10.1111/ans.16366] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Li CZ, Jiang XJ, Lin B, Hong HJ, Zhu SY, Jiang L, Wang XQ, Tang NH, She FF, Chen YL. RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway. Onco Targets Ther 2018;11:2875-90. [PMID: 29844685 DOI: 10.2147/OTT.S159026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
92 Sivade A, Sempoux C, Voutsadakis I, Brunel C, Halkic N, Godat S, Duran R, Digklia A. Synchronous tumors of the pancreas and the gallbladder: a case report with targeted NGS evaluation. Ann Transl Med 2019;7:696. [PMID: 31930097 DOI: 10.21037/atm.2019.10.107] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Muszynska C, Lundgren L, Andersson R, Søland T, Lindell G, Sandström P, Andersson B. Incidental metastases and lymphoma of the gallbladder - an analysis of ten rare cases identified from a large national database. Scand J Gastroenterol 2019;54:350-8. [PMID: 31035806 DOI: 10.1080/00365521.2019.1588363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Bangash M, Alvi AR, Shahzad N, Shariff AH, Gill RC. Factors Associated with Premalignant Epithelial Changes in Chronic Calculous Cholecystitis: A Case-Control Study. World J Surg. 2018;42:1701-1705. [PMID: 29143087 DOI: 10.1007/s00268-017-4371-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Zhang M, Cai S, Zuo B, Gong W, Tang Z, Zhou D, Weng M, Qin Y, Wang S, Liu J, Ma F, Quan Z. Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway. Tumour Biol 2017;39:1010428317698359. [PMID: 28459363 DOI: 10.1177/1010428317698359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
96 Chandra S, Chandra H, Shukla SK, Sahu S. Fine-needle aspiration cytology of gallbladder with an attempt of cytomorphological classification. Cytojournal 2019;16:1. [PMID: 30820231 DOI: 10.4103/cytojournal.cytojournal_5_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
97 Diep R, Lombardo P, Schneider M. The growth rates of solitary gallbladder polyps compared to multi‐polyps: A quantitative analysis. Australas J Ultrason Med 2022;25:28-35. [DOI: 10.1002/ajum.12284] [Reference Citation Analysis]
98 Kawamoto M, Onishi H, Ozono K, Yamasaki A, Imaizumi A, Kamakura S, Nakano K, Oda Y, Sumimoto H, Nakamura M. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer. Oncotarget 2017;8:36211-24. [PMID: 28423707 DOI: 10.18632/oncotarget.16063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
99 Wietsma MFT, Molloy C, Bhimani N, de Savornin Lohman EAJ, Gill AJ, Andrici J, Samra J, de Reuver PR, Hugh TJ. Gallbladder carcinoma outcomes in an Australian tertiary referral hospital. ANZ J Surg 2021;91:603-8. [PMID: 33604992 DOI: 10.1111/ans.16663] [Reference Citation Analysis]
100 Gupta A, Gupta S, Mani R, Durgapal P, Goyal B, Rajput D, Rao S, Dhar P, Gupta M, Kishore S, Kant R. Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma. J Carcinog 2021;20:7. [PMID: 34321957 DOI: 10.4103/jcar.JCar_4_21] [Reference Citation Analysis]
101 Aagre SV, Tonse M, Talele A, Sharma S, Advani SH. Bevacizumab based chemotherapy is a promising option in metastatic gallbladder adenocarcinoma. Mol Clin Oncol 2021;15:153. [PMID: 34178324 DOI: 10.3892/mco.2021.2315] [Reference Citation Analysis]
102 Feng F, Cheng Q, Yang L, Zhang D, Ji S, Zhang Q, Lin Y, Li F, Xiong L, Liu C, Jiang X. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing. Oncotarget 2017;8:5349-60. [PMID: 28029662 DOI: 10.18632/oncotarget.14146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
103 DeSimone MS, Goodman M, Pehlivanoglu B, Memis B, Balci S, Roa JC, Jang KT, Jang JY, Hong SM, Lee K, Kim H, Choi HJ, Muraki T, Araya JC, Bellolio E, Sarmiento JM, Maithel SK, Losada HF, Basturk O, Reid MD, Koshiol J, Adsay V. T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences. Virchows Arch 2021;478:875-84. [PMID: 33411027 DOI: 10.1007/s00428-020-02968-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Ng YS, Ananthakrishnan L. Imaging of the Gallbladder with Multi-energy CT. Curr Radiol Rep 2018;6. [DOI: 10.1007/s40134-018-0305-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Sharma P, Caldwell TS, Rivera MN, Gullapalli RR. Cadmium exposure activates Akt/ERK Signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism. Toxicol In Vitro 2020;67:104912. [PMID: 32512147 DOI: 10.1016/j.tiv.2020.104912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Fan B, Xu X, Wang X. Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer. Mol Biol Rep 2022;49:1295-301. [PMID: 34988893 DOI: 10.1007/s11033-021-06957-y] [Reference Citation Analysis]
107 Wang L, Dong P, Zhang Y, Yang M, Chen Y, Tian BL. Prognostic validation of the updated 8th edition Tumor-Node-Metastasis classification by the Union for International Cancer Control: Survival analyses of 307 patients with surgically treated gallbladder carcinoma. Oncol Lett 2018;16:4427-33. [PMID: 30214577 DOI: 10.3892/ol.2018.9189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
108 Albrecht T, Brinkmann F, Albrecht M, Lonsdorf AS, Mehrabi A, Hoffmann K, Kulu Y, Charbel A, Vogel MN, Rupp C, Köhler B, Springfeld C, Schirmacher P, Roessler S, Goeppert B. Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer. Cancers (Basel) 2021;13:1682. [PMID: 33918309 DOI: 10.3390/cancers13071682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Do SI, Lee HW, Sohn JH, Kim K. Clinicopathologic characteristics of young patients with gallbladder cancer. Pathol Res Pract 2017;213:189-93. [PMID: 28216138 DOI: 10.1016/j.prp.2016.12.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
110 De Paolis E, Urbani A, Salvatore L, Foca L, Tortora G, Minucci A, Concolino P. A Novel ATM Pathogenic Variant in an Italian Woman with Gallbladder Cancer. Genes (Basel) 2021;12:313. [PMID: 33671809 DOI: 10.3390/genes12020313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Blandino A, Scherer D, Rounge TB, Umu SU, Boekstegers F, Barahona Ponce C, Marcelain K, Gárate-Calderón V, Waldenberger M, Morales E, Rojas A, Munoz C, Retamales J, de Toro G, Barajas O, Rivera MT, Cortés A, Loader D, Saavedra J, Gutiérrez L, Ortega A, Bertrán ME, Gabler F, Campos M, Alvarado J, Moisán F, Spencer L, Nervi B, Carvajal-Hausdorf DE, Losada H, Almau M, Fernández P, Gallegos I, Olloquequi J, Fuentes-Guajardo M, Gonzalez-Jose R, Bortolini MC, Gallo C, Linares AR, Rothhammer F, Lorenzo Bermejo J. Identification of Circulating lncRNAs Associated with Gallbladder Cancer Risk by Tissue-Based Preselection, Cis-eQTL Validation, and Analysis of Association with Genotype-Based Expression. Cancers (Basel) 2022;14:634. [PMID: 35158906 DOI: 10.3390/cancers14030634] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Oven Ustaalioglu BB, Bilici A, Seker M, Kefeli U, Aydin D, Celik S, Demir T, Erkol B. Prognostic Factors for Operated Gallbladder Cancer. J Gastrointest Canc 2019;50:451-7. [DOI: 10.1007/s12029-018-0099-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC. Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. J Surg Oncol 2018;117:1664-71. [DOI: 10.1002/jso.25050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
114 Kirishima M, Yokoyama S, Matsuo K, Hamada T, Shimokawa M, Akahane T, Sugimoto T, Tsurumaru H, Ishibashi M, Mataki Y, Ootsuka T, Nomoto M, Hayashi C, Horiguchi A, Higashi M, Tanimoto A. Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis. BMC Microbiol 2022;22:147. [PMID: 35624429 DOI: 10.1186/s12866-022-02557-3] [Reference Citation Analysis]
115 Azees PAA, Natarajan S, Amaechi BT, Thajuddin N, Raghavendra VB, Brindhadevi K, Pugazhendhi A. An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies. Process Biochemistry 2022. [DOI: 10.1016/j.procbio.2022.04.013] [Reference Citation Analysis]
116 Wang S, Liu C, Liu X, He Y, Shen D, Luo Q, Dong Y, Dong H, Pang Z. Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines. Tumour Biol 2017;39:1010428317718192. [PMID: 29034777 DOI: 10.1177/1010428317718192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
117 Song H, Huang Y, Jiang X. Mutation spectrum associated with metastasis of advanced cholangiocarcinoma. J Int Med Res 2022;50:3000605221102080. [PMID: 35726602 DOI: 10.1177/03000605221102080] [Reference Citation Analysis]
118 Zhu AX, Pawlik TM, Kooby DA, Schefter TE, Vauthey J. Gallbladder. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 303-9. [DOI: 10.1007/978-3-319-40618-3_24] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
119 Raj G, Singh B, Raj R, Singh R. Lymph Nodal Metastatic Pattern in Carcinoma Gallbladder with Multidetector Computed Tomography: An Institutional Experience. Asian Journal of Oncology 2021;7:22-7. [DOI: 10.1055/s-0040-1714306] [Reference Citation Analysis]
120 Tsuchiya Y, Loza E, Villa-Gomez G, Trujillo CC, Baez S, Asai T, Ikoma T, Endoh K, Nakamura K. Metagenomics of Microbial Communities in Gallbladder Bile from Patients with Gallbladder Cancer or Cholelithiasis. Asian Pac J Cancer Prev 2018;19:961-7. [PMID: 29693356 DOI: 10.22034/APJCP.2018.19.4.961] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
121 Ma Q, Zhang Y, Liang H, Zhang F, Liu F, Chen S, Hu Y, Jiang L, Hao Y, Li M, Liu Y. EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway. Cancer Letters 2018;430:97-108. [DOI: 10.1016/j.canlet.2018.05.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
122 Min JH, Kang TW, Cha DI, Kim SH, Shin KS, Lee JE, Jang K, Ahn SH. Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer. Eur Radiol 2019;29:411-21. [DOI: 10.1007/s00330-018-5602-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
123 Yu MH, Kim YJ, Park HS, Jung SI. Benign gallbladder diseases: Imaging techniques and tips for differentiating with malignant gallbladder diseases. World J Gastroenterol 2020; 26(22): 2967-2986 [PMID: 32587442 DOI: 10.3748/wjg.v26.i22.2967] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
124 Machairas N, Paspala A, Frountzas M, Tsilimigras DI, Moris D, Ntomi V, Tsapralis D, Schizas D. Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gallbladder: A Systematic Review of Outcomes Following Surgical Management. In Vivo 2019;33:1721-6. [PMID: 31662496 DOI: 10.21873/invivo.11662] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
125 Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 2020;145:102854. [PMID: 31877535 DOI: 10.1016/j.critrevonc.2019.102854] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 27.7] [Reference Citation Analysis]
126 Wang J, Yang Y, Pan J, Qiu Y, Shen S, Wang W. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study. Jpn J Clin Oncol 2022:hyab212. [PMID: 35137118 DOI: 10.1093/jjco/hyab212] [Reference Citation Analysis]
127 Qin H, Yuan B, Huang W, Wang Y. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances. Front Oncol 2022;12:924696. [DOI: 10.3389/fonc.2022.924696] [Reference Citation Analysis]
128 Song F, Yang Z, Li L, Wei Y, Tang X, Liu S, Yu M, Chen J, Wang S, Fu J, Zhang K, Yang P, Yang X, Chen Z, Zhang B, Wang H. MiR-552-3p promotes malignant progression of gallbladder carcinoma by reactivating the Akt/β-catenin signaling pathway due to inhibition of the tumor suppressor gene RGMA. Ann Transl Med 2021;9:1374. [PMID: 34733926 DOI: 10.21037/atm-21-2013] [Reference Citation Analysis]
129 Beal EW, Lyon E, Kearney J, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, Weber SM, Tran TB, Poultsides G, Shenoy R, Hatzaras I, Krasnick B, Fields RC, Buttner S, Scoggins CR, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Pawlik TM, Schmidt CR. Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) 2017;19:1104-11. [PMID: 28890310 DOI: 10.1016/j.hpb.2017.08.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]